Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial

BACKGROUND: The presence of tumour-infiltrating lymphocytes (TILs) is associated with response to neoadjuvant chemotherapy among patients with triple-negative and HER2-positive breast cancer. However, the significance of TILs is less clear in luminal breast cancer. Here, we in postmenopausal patient...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Breast Cancer Res
Main Authors: Skriver, Signe Korsgaard, Jensen, Maj-Britt, Knoop, Ann Soegaard, Ejlertsen, Bent, Laenkholm, Anne-Vibeke
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7222485/
https://ncbi.nlm.nih.gov/pubmed/32410705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01285-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki